Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

111 Inc ADR (YI)

111 Inc ADR (YI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 560,041
  • Shares Outstanding, K 82,359
  • Annual Sales, $ 567,680 K
  • Annual Income, $ -71,760 K
  • 60-Month Beta 1.15
  • Price/Sales 1.04
  • Price/Cash Flow N/A
  • Price/Book 7.09
Trade YI with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +356,885.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.31 +10.46%
on 11/03/20
7.54 -7.56%
on 11/19/20
-0.03 (-0.43%)
since 10/23/20
3-Month
5.20 +34.04%
on 09/08/20
7.54 -7.56%
on 11/19/20
+0.09 (+1.31%)
since 08/21/20
52-Week
4.46 +56.28%
on 12/26/19
8.70 -19.89%
on 01/29/20
+1.87 (+36.67%)
since 11/22/19

Most Recent Stories

More News
111: 3Q Earnings Snapshot

SHANGHAI (AP) _ 111 Inc. (YI) on Thursday reported a loss of $16 million in its third quarter.

YI : 6.97 (+2.50%)
111, Inc. Announces Third Quarter 2020 Unaudited Financial Results

, /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform committed to digitally connecting patients with medicine and healthcare services in , today announced...

YI : 6.97 (+2.50%)
111 to Announce Third Quarter 2020 Unaudited Financial Results on November 19, 2020

, /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading digital healthcare platform committed to digitally connecting patients with healthcare products and services in , today announced...

YI : 6.97 (+2.50%)
111, Inc. Teams Up with Bayer Healthcare to Explore the Vast Blue Ocean of Online Healthcare

, /PRNewswire/ -- On , 111, Inc. (the "Company" or "111") entered into a strategic partnership (the "Partnership") with ("Bayer Healthcare"). The two companies will collaborate on drug commercialization...

YI : 6.97 (+2.50%)
111, Inc. Teams Up with Huluwa Pharmaceutical to Explore the New Domain of "Internet + pharmaceutical"

, /PRNewswire/ -- On , 111, Inc. (NASDAQ: YI) (the "Company" or "111") and Hainan Huluwa Pharmaceutical Group Co., Ltd. (SH: 605199) ("Huluwa Pharmaceutical") signed a strategic partnership agreement...

YI : 6.97 (+2.50%)
111 to be the Omni-channel Drug Commercialization Partner of Xiangxu Pharmaceutical for Traditional Chinese Medicine

, /PRNewswire/ -- On , 111, Inc. (the "Company" or "111") and Guangzhou Xiangxue Pharmaceutical Co., Ltd. ("Xiangxue Pharmaceutical") officially signed a strategic partnership agreement (the "Agreement")...

YI : 6.97 (+2.50%)
111, Inc. and Shanghai Uniondrug Information Technology Join Hands to Advance Innovation in Commercial Insurance Payment

, /PRNewswire/ -- On , 111, Inc. (NASDAQ: YI) ("111") and Shanghai Uniondrug Information Technology Co., Ltd ("Shanghai Uniondrug") officially signed a strategic partnership agreement (the "Agreement")....

YI : 6.97 (+2.50%)
111, Inc. Builds Digitally-enabled, Omni-channel Drug Commercialization Platform as Part of its Goal to Provide Full Life-cycle Healthcare Management Solutions for Patients

, /PRNewswire/ -- On , 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform dedicating to digitally connecting patients with drugs and healthcare services in , hosted...

YI : 6.97 (+2.50%)
111, Inc. Partners with Baiyunshan Pharmaceutical Sales in Digital Medicine Innovation

, /PRNewswire/ -- On , 111, Inc. ("111" or the "Company") (Nasdaq: YI), a company dedicated to digitally connecting patients with drugs and healthcare services in , and Guangzhou Baiyunshan Pharmaceutical...

YI : 6.97 (+2.50%)
111: 2Q Earnings Snapshot

SHANGHAI (AP) _ 111 Inc. (YI) on Thursday reported a loss of $13.1 million in its second quarter.

YI : 6.97 (+2.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.

See More

Key Turning Points

2nd Resistance Point 7.31
1st Resistance Point 7.14
Last Price 6.97
1st Support Level 6.80
2nd Support Level 6.63

See More

52-Week High 8.70
Fibonacci 61.8% 7.08
Last Price 6.97
Fibonacci 50% 6.58
Fibonacci 38.2% 6.08
52-Week Low 4.46

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar